SEC EDGAR / Filings

SEC filings of major AI / tech companies, made readable

Key filings (8-K current, 10-K annual, 10-Q quarterly, etc.) that U.S.-listed companies submit to SEC EDGAR, organized with form type, 8-K events, and filing date. Each filing links to the official primary source (SEC).

This page organizes public statutory disclosures and is not investment advice. Investment decisions are your own responsibility; always verify with the original filing and a professional. This site is not an official U.S. government or SEC site.

Browse all collected data (list, filter, search) →

Featured

Featured

Recent high-importance disclosures, explained with key points, FAQs, and sources.

Current report (8-K) MSFT MICROSOFT CORP 2026/06/05

Microsoft director Reid Hoffman will not stand for re-election at the 2026 annual meeting (8-K, June 2026)

Microsoft disclosed in an 8-K that Reid Hoffman (LinkedIn co-founder), a director since 2017, notified the company on June 2, 2026 that he will not stand for re-election at the 2026 annual meeting. The filing states it is not due to any disagreement over management policy, and he remains a director until the meeting.

  • Reid Hoffman (LinkedIn co-founder; director since 2017) will not stand for re-election at the 2026 meeting
  • The 8-K explicitly states it is "not due to any disagreement over management policy" (boilerplate Item 5.02 disclosure)
  • He remains a director until the meeting; successor / board composition to be confirmed in future DEF 14A, etc.
Read more
Current report (8-K) GOOGL Alphabet Inc. 2026/06/04

Alphabet (Google's parent) sets up an ATM equity program of up to $40B (8-K, June 2026)

Alphabet disclosed in an 8-K that, effective June 1, 2026, it entered an "Equity Distribution Agreement" with Goldman Sachs, J.P. Morgan, and Morgan Stanley, setting up an at-the-market (ATM) program to sell Class A common and Class C capital stock at market prices up to $40 billion over time. There is no obligation to sell, and it can be suspended at the company's discretion at any time.

  • Set up an ATM (at-the-market) program of up to $40B combined in Class A common and Class C capital stock
  • Sales agents are Goldman Sachs, J.P. Morgan, and Morgan Stanley (agreement dated June 1, 2026)
  • No obligation to issue; price/timing/size at the company's discretion and suspendable anytime — setup is not immediate dilution
Read more
Current report (8-K) NOW ServiceNow, Inc. 2026/05/15

ServiceNow issues $4B of notes (five tranches, maturing 2028–2056; 8-K, May 2026)

ServiceNow disclosed in an 8-K that on May 15, 2026 it completed an offering of $4 billion in senior notes, in five tranches: 4.250% (2028), 4.700% (2031), 5.050% (2033), 5.400% (2036), and 6.300% (2056). Underwriters were Barclays, Citi, J.P. Morgan, and Wells Fargo.

  • Completed a $4B senior (unsecured) notes offering on May 15, 2026
  • Five tranches: 4.250%/2028, 4.700%/2031, 5.050%/2033, 5.400%/2036, 6.300%/2056
  • Underwriter representatives: Barclays, Citi, J.P. Morgan, Wells Fargo; issued under Form S-3
Read more
Current report (8-K) AMD ADVANCED MICRO DEVICES INC 2026/05/15

AMD renews a $5B five-year unsecured revolving credit facility (8-K, May 2026)

AMD disclosed in an 8-K that on May 14, 2026 it entered a $5 billion, five-year unsecured revolving credit facility with J.P. Morgan as administrative agent, replacing its existing 2022 facility. No amount was drawn at signing. Interest is Term SOFR + 0.50–0.80%, etc.

  • Entered a new $5B, five-year unsecured revolving credit facility (dated May 14, 2026)
  • Replaces the existing 2022 facility; administrative agent is J.P. Morgan Chase
  • No amount outstanding at signing = securing/renewing standby liquidity (not an actual drawdown)
Read more
Current report (8-K) ORCL ORACLE CORP 2026/05/12

Oracle appoints Cleveland Clinic CEO Dr. T. Mihaljevic to its board (8-K, May 2026)

Oracle disclosed that on May 6, 2026 its board unanimously appointed Dr. Tomislav Mihaljevic, CEO and President of Cleveland Clinic, as a director (effective immediately), expanding the board to 13. Bringing on the head of a major medical institution reflects Oracle's healthcare focus.

  • Cleveland Clinic CEO/President Dr. T. Mihaljevic unanimously appointed director (effective May 6, 2026)
  • Board expanded to 13; standard RSU and cash compensation for non-employee directors granted
  • No third-party arrangement and no related-party transaction stated (Items 5.02 / 7.01)
Read more
New (key filings, original)

Recent filings

Key filings recently submitted by covered companies (8-K/10-K/10-Q, etc.). For 8-K, the event types are also shown. Each filing links to the official SEC source.

Source: SEC EDGAR (public domain). Links go to the official filings.

Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.